HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin-22 aggravates murine acute graft-versus-host disease by expanding effector T cell and reducing regulatory T cell.

Abstract
Graft-versus-host disease (GVHD) as a major complication after allogeneic hematopoietic stem cell transplantation is not well prevented now. We have observed that interleukin-22 (IL-22) produced by Th22, Th1, and Th17 cells participated in GVHD development in our previous study. However, the role of IL-22 in GVHD is still ambiguous. The aim of this study was to illuminate the pathological or protective function and the potential mechanism of IL-22 in the GVHD process. In the present study, we found that compared with mice cotransferred with bone marrow and spleen cells (BS mice) without IL-22 administration, more serious tissue damage and higher GVHD clinical score were observed in BS+IL-22 mice. IL-22 administration was a benefit to early recovery of thymus after irradiation-induced injury. Administration of IL-22 could promote Th1 and Tc1 cell expansion in mesenteric lymph nodes but reduce CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cell number. Levels of systemic inflammatory cytokines (IFN-γ and TNF-α) were upregulated, while the level of immunosuppressive cytokine IL-10 was downregulated in recipients with IL-22 injection. In conclusion, IL-22, which exacerbates both local immune responses and systemic inflammation of recipients, plays a pathogenic role in the GVHD process. The potential mechanism of IL-22 in GVHD may attribute to increased alloreactive effector Th1 and Tc1 cells and decreased inhibitory Treg cell.
AuthorsKai Zhao, Dongmei Zhao, Dong Huang, Lingling Yin, Chong Chen, Bin Pan, Qingyun Wu, Zhenyu Li, Yao Yao, Erxia Shen, Lingyu Zeng, Kailin Xu
JournalJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research (J Interferon Cytokine Res) Vol. 34 Issue 9 Pg. 707-15 (Sep 2014) ISSN: 1557-7465 [Electronic] United States
PMID24720737 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukins
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma
  • interleukin-22
Topics
  • Animals
  • Bone Marrow Cells (immunology)
  • Down-Regulation (immunology)
  • Graft vs Host Disease (immunology)
  • Interferon-gamma (immunology)
  • Interleukins (genetics, immunology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Spleen (immunology)
  • T-Lymphocytes, Regulatory (immunology)
  • Th1 Cells (immunology)
  • Th17 Cells (immunology)
  • Tumor Necrosis Factor-alpha (immunology)
  • Up-Regulation (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: